US Stock MarketDetailed Quotes

LVTX LAVA Therapeutics

Watchlist
  • 1.575
  • -0.085-5.12%
Trading Nov 15 14:12 ET
41.42MMarket Cap-1769P/E (TTM)

LAVA Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
35.83%-8.38M
86.50%-1.13M
-1,063.94%-38.97M
-128.32%-10.12M
48.05%-7.45M
-34.41%-13.07M
-9.27%-8.34M
114.11%4.04M
580.70%35.74M
-75.40%-14.34M
Net income from continuing operations
34.85%-8.21M
96.51%-484K
-31.70%-41.7M
56.65%-6.44M
-993.79%-8.79M
-56.95%-12.6M
-42.06%-13.87M
24.98%-31.66M
-81.92%-14.85M
114.27%983K
Operating gains losses
-38.93%-339K
-169.48%-658K
148.31%1.41M
-52.06%1.84M
54.99%-1.13M
92.22%-244K
185.16%947K
-43.28%-2.92M
389.81%3.84M
-53.63%-2.52M
Depreciation and amortization
-22.71%228K
-21.09%247K
63.64%1.28M
29.89%352K
89.29%318K
69.54%295K
86.31%313K
39.96%781K
88.19%271K
11.26%168K
Deferred tax
12.37%-85K
2.82%-69K
-12.05%-279K
11.76%-60K
-10.87%-51K
-29.33%-97K
-18.33%-71K
-58.60%-249K
-17.24%-68K
-6.98%-46K
Change In working capital
91.47%-133K
-118.24%-581K
-108.29%-2.83M
-113.16%-6.05M
111.69%1.6M
-266.38%-1.56M
268.75%3.19M
214.78%34.11M
6,216.35%45.98M
-1,030.77%-13.67M
-Change in receivables
89.40%-254K
-41.10%758K
164.20%1.59M
-101.17%-557K
106.50%3.26M
-2,161.32%-2.4M
2,398.21%1.29M
-433.56%-2.48M
4,797.64%47.75M
-5,088.08%-50.07M
-Change in prepaid assets
-146.33%-947K
-60.36%463K
282.28%3.39M
164.83%446K
90.36%-273K
193.26%2.04M
20.91%1.17M
35.05%-1.86M
-140.52%-688K
-1,118.71%-2.83M
-Change in payables and accrued expense
-60.93%761K
0.11%-915K
-76.36%334K
-23.78%-4.76M
-18.06%4.07M
569.42%1.95M
-10,277.78%-916K
-12.67%1.41M
-698.44%-3.85M
2,030.35%4.96M
-Change in other current liabilities
109.73%307K
-153.86%-887K
-330.98%-8.14M
-144.27%-1.18M
-625.70%-5.45M
-588.99%-3.15M
70.32%1.65M
-75.48%3.52M
316.87%2.66M
-190.05%-751K
-Change in other working capital
----
----
----
----
----
----
----
1,207.40%33.51M
107.79%106K
3,286.17%35.02M
Cash from discontinued investing activities
Operating cash flow
35.83%-8.38M
86.50%-1.13M
-1,063.94%-38.97M
-128.32%-10.12M
48.05%-7.45M
-34.41%-13.07M
-9.27%-8.34M
114.11%4.04M
580.70%35.74M
-75.38%-14.34M
Investing cash flow
Cash flow from continuing investing activities
51.34%339K
-90.65%718K
-288.69%-17.64M
-109.88%-8.69M
-355.95%-16.85M
-93.66%224K
127.74%7.68M
121.46%9.35M
-404.14%-4.14M
115.47%6.58M
Net PPE purchase and sale
101.34%3K
117.80%89K
-24.36%-730K
--0
-124.00%-6K
-833.33%-224K
-54.80%-500K
23.17%-587K
-57.74%-265K
105.92%25K
Net investment purchase and sale
-25.00%336K
-92.31%629K
-270.19%-16.91M
-124.24%-8.69M
-356.83%-16.84M
-87.40%448K
121.36%8.18M
123.22%9.93M
-493.26%-3.87M
115.57%6.56M
Cash from discontinued investing activities
Investing cash flow
51.34%339K
-90.65%718K
-288.69%-17.64M
-109.88%-8.69M
-355.95%-16.85M
-93.66%224K
127.74%7.68M
121.46%9.35M
-404.14%-4.14M
115.47%6.58M
Financing cash flow
Cash flow from continuing financing activities
103.18%5K
0
-301.77%-571K
-1,025.00%-180K
-1,857.14%-137K
-536.11%-157K
-135.93%-97K
-99.81%283K
90.12%-16K
-103.24%-7K
Net issuance payments of debt
92.36%-12K
91.75%-8K
-313.06%-571K
-1,025.00%-180K
-1,857.14%-137K
-847.62%-157K
-135.93%-97K
-21.18%268K
90.12%-16K
-103.24%-7K
Net common stock issuance
----
----
--0
----
----
----
----
--0
----
----
Net preferred stock issuance
----
----
--0
----
----
----
----
--0
----
----
Proceeds from stock option exercised by employees
--17K
--8K
--0
--0
--0
--0
--0
--15K
--0
--0
Cash from discontinued financing activities
Financing cash flow
103.18%5K
--0
-301.77%-571K
-1,025.00%-180K
-1,857.14%-137K
-536.11%-157K
-135.93%-97K
-99.81%283K
90.06%-16K
-103.24%-7K
Net cash flow
Beginning cash position
-57.07%43.19M
-55.92%44.23M
10.41%100.33M
-2.59%62.66M
15.47%87.61M
17.36%100.6M
10.41%100.33M
474.47%90.87M
-35.90%64.33M
-50.31%75.87M
Current changes in cash
38.14%-8.04M
46.09%-407K
-518.21%-57.18M
-160.12%-18.99M
-214.60%-24.44M
-111.25%-13M
81.06%-755K
-82.69%13.67M
475.24%31.58M
84.62%-7.77M
Effect of exchange rate changes
-6,200.00%-61K
-162.09%-637K
125.57%1.08M
-87.45%555K
86.57%-506K
100.03%1K
188.52%1.03M
-7.43%-4.21M
508.97%4.42M
-109.51%-3.77M
End cash Position
-59.95%35.09M
-57.07%43.19M
-55.92%44.23M
-55.92%44.23M
-2.59%62.66M
15.47%87.61M
17.36%100.6M
10.41%100.33M
10.41%100.33M
-35.90%64.33M
Free cash flow
36.91%-8.38M
87.27%-1.13M
-1,248.78%-39.7M
-128.53%-10.12M
47.92%-7.46M
-36.38%-13.29M
-11.12%-8.84M
111.75%3.46M
566.59%35.47M
-66.48%-14.32M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 35.83%-8.38M86.50%-1.13M-1,063.94%-38.97M-128.32%-10.12M48.05%-7.45M-34.41%-13.07M-9.27%-8.34M114.11%4.04M580.70%35.74M-75.40%-14.34M
Net income from continuing operations 34.85%-8.21M96.51%-484K-31.70%-41.7M56.65%-6.44M-993.79%-8.79M-56.95%-12.6M-42.06%-13.87M24.98%-31.66M-81.92%-14.85M114.27%983K
Operating gains losses -38.93%-339K-169.48%-658K148.31%1.41M-52.06%1.84M54.99%-1.13M92.22%-244K185.16%947K-43.28%-2.92M389.81%3.84M-53.63%-2.52M
Depreciation and amortization -22.71%228K-21.09%247K63.64%1.28M29.89%352K89.29%318K69.54%295K86.31%313K39.96%781K88.19%271K11.26%168K
Deferred tax 12.37%-85K2.82%-69K-12.05%-279K11.76%-60K-10.87%-51K-29.33%-97K-18.33%-71K-58.60%-249K-17.24%-68K-6.98%-46K
Change In working capital 91.47%-133K-118.24%-581K-108.29%-2.83M-113.16%-6.05M111.69%1.6M-266.38%-1.56M268.75%3.19M214.78%34.11M6,216.35%45.98M-1,030.77%-13.67M
-Change in receivables 89.40%-254K-41.10%758K164.20%1.59M-101.17%-557K106.50%3.26M-2,161.32%-2.4M2,398.21%1.29M-433.56%-2.48M4,797.64%47.75M-5,088.08%-50.07M
-Change in prepaid assets -146.33%-947K-60.36%463K282.28%3.39M164.83%446K90.36%-273K193.26%2.04M20.91%1.17M35.05%-1.86M-140.52%-688K-1,118.71%-2.83M
-Change in payables and accrued expense -60.93%761K0.11%-915K-76.36%334K-23.78%-4.76M-18.06%4.07M569.42%1.95M-10,277.78%-916K-12.67%1.41M-698.44%-3.85M2,030.35%4.96M
-Change in other current liabilities 109.73%307K-153.86%-887K-330.98%-8.14M-144.27%-1.18M-625.70%-5.45M-588.99%-3.15M70.32%1.65M-75.48%3.52M316.87%2.66M-190.05%-751K
-Change in other working capital ----------------------------1,207.40%33.51M107.79%106K3,286.17%35.02M
Cash from discontinued investing activities
Operating cash flow 35.83%-8.38M86.50%-1.13M-1,063.94%-38.97M-128.32%-10.12M48.05%-7.45M-34.41%-13.07M-9.27%-8.34M114.11%4.04M580.70%35.74M-75.38%-14.34M
Investing cash flow
Cash flow from continuing investing activities 51.34%339K-90.65%718K-288.69%-17.64M-109.88%-8.69M-355.95%-16.85M-93.66%224K127.74%7.68M121.46%9.35M-404.14%-4.14M115.47%6.58M
Net PPE purchase and sale 101.34%3K117.80%89K-24.36%-730K--0-124.00%-6K-833.33%-224K-54.80%-500K23.17%-587K-57.74%-265K105.92%25K
Net investment purchase and sale -25.00%336K-92.31%629K-270.19%-16.91M-124.24%-8.69M-356.83%-16.84M-87.40%448K121.36%8.18M123.22%9.93M-493.26%-3.87M115.57%6.56M
Cash from discontinued investing activities
Investing cash flow 51.34%339K-90.65%718K-288.69%-17.64M-109.88%-8.69M-355.95%-16.85M-93.66%224K127.74%7.68M121.46%9.35M-404.14%-4.14M115.47%6.58M
Financing cash flow
Cash flow from continuing financing activities 103.18%5K0-301.77%-571K-1,025.00%-180K-1,857.14%-137K-536.11%-157K-135.93%-97K-99.81%283K90.12%-16K-103.24%-7K
Net issuance payments of debt 92.36%-12K91.75%-8K-313.06%-571K-1,025.00%-180K-1,857.14%-137K-847.62%-157K-135.93%-97K-21.18%268K90.12%-16K-103.24%-7K
Net common stock issuance ----------0------------------0--------
Net preferred stock issuance ----------0------------------0--------
Proceeds from stock option exercised by employees --17K--8K--0--0--0--0--0--15K--0--0
Cash from discontinued financing activities
Financing cash flow 103.18%5K--0-301.77%-571K-1,025.00%-180K-1,857.14%-137K-536.11%-157K-135.93%-97K-99.81%283K90.06%-16K-103.24%-7K
Net cash flow
Beginning cash position -57.07%43.19M-55.92%44.23M10.41%100.33M-2.59%62.66M15.47%87.61M17.36%100.6M10.41%100.33M474.47%90.87M-35.90%64.33M-50.31%75.87M
Current changes in cash 38.14%-8.04M46.09%-407K-518.21%-57.18M-160.12%-18.99M-214.60%-24.44M-111.25%-13M81.06%-755K-82.69%13.67M475.24%31.58M84.62%-7.77M
Effect of exchange rate changes -6,200.00%-61K-162.09%-637K125.57%1.08M-87.45%555K86.57%-506K100.03%1K188.52%1.03M-7.43%-4.21M508.97%4.42M-109.51%-3.77M
End cash Position -59.95%35.09M-57.07%43.19M-55.92%44.23M-55.92%44.23M-2.59%62.66M15.47%87.61M17.36%100.6M10.41%100.33M10.41%100.33M-35.90%64.33M
Free cash flow 36.91%-8.38M87.27%-1.13M-1,248.78%-39.7M-128.53%-10.12M47.92%-7.46M-36.38%-13.29M-11.12%-8.84M111.75%3.46M566.59%35.47M-66.48%-14.32M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data